Featured Research

from universities, journals, and other organizations

Insight offers new angle of attack on variety of brain tumors

Date:
December 19, 2010
Source:
Brown University
Summary:
Scientists have associated a mutation found in many kinds of brain tumors with a molecular process that affects metabolism genes. The discovery may open the door to developing new treatments for the deadly cancers.

A newly published insight into the biology of many kinds of less-aggressive but still lethal brain tumors, or gliomas, opens up a wide array of possibilities for new therapies, according to scientists at Brown University and the University of California, San Francisco (UCSF). In paper published online Dec. 15 in the Journal of the National Cancer Institute, they describe how a genetic mutation leads to an abnormal metabolic process in the tumors that could be targeted by drug makers.

Related Articles


"What this tells you is that there are some forms of tumors with a fundamentally altered process," said Karl Kelsey, a professor of pathology and laboratory medicine and community health in the Warren Alpert Medical School of Brown and one of the paper's senior authors. "This is a really new way to look at potentially modifiable factors in brain tumors."

Scientists have known for a couple of years that a mutation in a gene called IDH is associated with glioma. They've also observed that people with gliomas carrying the mutation survive longer than those afflicted with tumors lacking the mutation. What the Brown and UCSF team show in the new paper is that the mutation is associated with a consistent pattern of an alteration known as "methylation" of the DNA which is associated with changes in gene expression. The pattern of methylation in tumors with the IDH mutation often occurred in metabolic genes, regardless of the tumor's specific type.

Margaret Wrensch, a professor of neurological surgery, epidemiology and biostatistics at UCSF's Helen Diller Family Comprehensive Cancer Center, said what the team found surprising is that DNA from almost all tumors with IDH mutations had the same distinctive methylation pattern. The degree of methylation throughout the genome was unusually high, and the same specific DNA was methylated.

"This one mutation is common to a whole subset of brain tumors," she said. "It's quite unique. It seems to dominate other mutations in the tumor and the epigenetic changes are very uniform."

The researchers hope now that if a drug could inhibit this methylation process in any number of these affected genes, not necessarily just IDH, that might correct the errant metabolism of the tumors and control their growth.

"We know now that there are all these genes related to metabolism that have altered methylation," said Brock Christensen, a Brown postdoctoral scholar in pathology and laboratory medicine and a lead author of the paper, which also involved researchers from the University of Minnesota and Dartmouth Medical School. "In this suite of genes there might be a much easier target to try to design a therapy for."

The heart of the study was a tumor-by-tumor analysis of the methlylation, led by Christensen and Brown graduate student Ashley Smith, in scores of samples from the Brain Tumor Research Center at UCSF. Their analysis revealed an unusually iron clad correlation between the IDH mutation and methylation in metabolic genes in gliomas of many different names and classifications.

"The strength of the correlation was absolutely stunning," Christensen said. "It's not the kind of thing you see very often in cancer epidemiology, to have almost all of these mutant tumors having the same methylation profile."

The IDH gene has a role in glucose sensing, so the association of the mutation with altered metabolism genes (occurring through enhanced DNA methylation) is reasonable, Christensen said. The researchers are now looking into the role that mutation in IDH plays in perhaps altering other metabolism genes in the cells.

The research leaves many questions about brain tumors unanswered. Among them is what causes the IDH mutation, what causes the mutation to affect other genes in the cell, and most importantly, what is the best way take therapeutic advantage of these new observations.

But Kelsey said the fight against brain cancer has long had a dearth of hope, so he's encouraged to see some emerge.

"Gliomas are such a deadly disease, and so little is known about them, that people are pretty excited about this because it is a whole new way in," he said. "We have a new clue about what to study."

Along with Kelsey and Wrensch, a third joint lead investigator was John K. Wiencke in the department of Neurological Surgery at UCSF. Other authors were Carmen Marsit, E. Andres Houseman and Devin C. Koestler of Brown; Shichun Zheng and Joseph Wiemels of UCSF; Heather H. Nelson of Minnesota; and Margaret R. Karagas of Dartmouth.

Funding for the research came from several grants from the National Institutes of Health.


Story Source:

The above story is based on materials provided by Brown University. Note: Materials may be edited for content and length.


Cite This Page:

Brown University. "Insight offers new angle of attack on variety of brain tumors." ScienceDaily. ScienceDaily, 19 December 2010. <www.sciencedaily.com/releases/2010/12/101215163746.htm>.
Brown University. (2010, December 19). Insight offers new angle of attack on variety of brain tumors. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2010/12/101215163746.htm
Brown University. "Insight offers new angle of attack on variety of brain tumors." ScienceDaily. www.sciencedaily.com/releases/2010/12/101215163746.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins